Experts Matter. Find Yours.
Connect for media, speaking, professional opportunities & more.
Vanderbilt historian and Henry Kissinger biographer on Kissinger legacy ahead of 100th birthday
Thomas Schwartz, Distinguished Professor of History, is available for commentary surrounding the legacy of Henry Kissinger, former U.S. Secretary of State and National Security Advisor, ahead of his 100th birthday (May 27, 2023). A historian of U.S. foreign relations, American politics, international relations and Modern European history, Thomas is the author of “Henry Kissinger and American Power: A Political Biography.” Thomas can discuss Kissinger’s: Mixed bag legacy, receiving both praise for his guidance throughout the decades and criticism for his more controversial decisions Approach to foreign policy and leadership style, including: ability to recognize failures, penchant for backbiting and reliance on flattery and praise of the president as a source of power Invention of himself as a celebrity diplomat and his domination of TV news Sensitivity to domestic and partisan politics
Comprehensive Sleep Wellness Center Opens on Newark Campus
More than 70 million Americans suffer from sleep-related problems. To address this growing need, ChristianaCare has opened a new comprehensive sleep wellness center in the Medical Arts Pavilion II on the ChristianaCare Newark Campus. The ChristianaCare Sleep Wellness Center, accredited by the American Academy of Sleep Medicine, is an outpatient program that provides expert diagnosis and treatment of sleep disorders. The nearly 5,000 square foot, seven-bed facility builds on the success of ChristianaCare’s previous sleep diagnostic center, now incorporating clinical care and diagnostic testing at the same site. The center is staffed by board-certified sleep medicine specialists who provide in-lab and at-home sleep testing, as well as a behavioral health specialist who offers cognitive behavioral therapy for insomnia. The center offers onsite and virtual appointments. “At the ChristianaCare Sleep Wellness Center, we offer the full range of sleep care services in one place, with the expertise to help people with all kinds of sleep disorders,” said Shilpa Kauta, M.D., medical director of the ChristianaCare Sleep Wellness Center. “Sleep disorders affect members of every race, socioeconomic class and age group, but despite the high prevalence of sleep disorders, many people remain undiagnosed and untreated,” she said. National surveys show that more than 60 percent of adults have never been asked about the quality of their sleep by a physician. “It’s important for people to know that if they have problems related to sleeping, they should talk to their doctor about it, or call us at the Sleep Wellness Center. Sleep disorders can affect overall health—and they are often very treatable.” The Sleep Wellness Center provides expert, multidisciplinary diagnosis and care for every kind of sleep problem, including: Obstructive sleep apnea. Restless leg syndrome. Narcolepsy. Parasomnias, such as sleepwalking. As part of the ChristianaCare team, the expert staff at the Sleep Wellness Center coordinates with disease-based programs at ChristianaCare to integrate sleep services into cardiac care, weight loss surgery and renal transplant care. They also partner with surgeons to manage hypoglossal nerve stimulation therapy, a major advancement in obstructive sleep apnea treatment. Patients at the Sleep Wellness Center undergo a personal sleep history, medical background and physical examination. If appropriate, a polysomnography (sleep study) may be ordered to monitor and record brain waves, heart rate, blood oxygen level, breathing and eye movements. Poor Sleep Health is a National Problem According to the National Institutes of Health, of the 70 million Americans suffering from sleep-related problems, more than 50% are likely to have a chronic disorder, such as insomnia, obstructive sleep apnea, restless leg syndrome and narcolepsy. People who suffer from sleep disorders are also more likely to have chronic diseases like hypertension, diabetes, depression, obesity and even cancer. The impact on American life and economy is enormous as sleep deprivation and untreated sleep disorders are estimated to cost over $100 billion annually in lost productivity, medical expenses, sick leave, property and environmental damage. “With information collected through testing, our sleep experts can determine the source of a sleep problem and begin a treatment plan to help patients improve their quality of life,” Kauta said. The address and phone number of the new center: ChristianaCare Sleep Wellness Center 4735 Ogletown Stanton Rd. Suite 2210 Newark, DE 19713 302-623-0610
Coronation of King Charles III: Augusta University professor talks about what to expect
Eyes from around the world will be on Westminster Abbey in London this weekend as King Charles III is crowned king following the passing his mother Queen Elizabeth II on Sept. 8, 2022. As you might expect, there will be plenty of pageantry involved with the ceremony. Ruth McClelland-Nugent, PhD, is chair of History, Anthropology and Philosophy at Pamplin College of Arts, Humanities, and Social Sciences at Augusta University and an expert on the royal family. McClelland-Nugent said this is a major day for those in the United Kingdom, and to a lesser extent, some parts of the Commonwealth "where the British monarch is still monarch, such as Charles will become king of Canada as well as the U.K." The coronation is a religious service of the Church of England, so there will be a number of traditions upheld, such as anointing of the king with blessed oil, and by the end of the ceremony, Charles will have officially received his crown and his scepter, as well as the traditional robes and stole that mark him as king. The crown and the orb that will be used during the coronation date back to 1661 for King Charles II. New crowns were needed after the Puritans melted the old ones down during the English Civil Wars. “These are very traditional things, and reinforce the ancient idea that the monarch is selected by God to have authority over people,” said McClelland-Nugent. "However, for the first time, there will be participation from clergy of other faiths as well, since the king has invited clergy from the Jewish, Sikh, Hindu, Muslim and Buddhist faiths to participate, reflecting the great religious diversity in the U.K.” She also said those watching the coronation, in-person or virtually, will be invited to swear an oath of allegiance to the monarch, giving the entire country a role in the ceremony for the first time. “It will probably feel very formal and ancient to any Americans who watch it, and it is, but it will be the most informal and diverse coronation in recent British history,” McClelland-Nugent said. Others in the royal family will also play roles in the ceremony. Queen Camilla will be crowned alongside Charles. Princess Anne, Charles' sister, will lead a procession of armed forces and other personnel behind the new king and queen when they leave Westminster Abbey. “Look for her to be on horseback. This is a highly prestigious role and not one carried out by a woman previously.” McClelland-Nugent said Prince William, Prince of Wales, who is now heir to the crown, will make an oath of loyalty directly to the newly crowned king. Some of the king’s grandchildren and queen’s grandchildren will also serve roles during the coronation. If you're a reporter covering the coronation and all the events leading up to it this week, then let our experts help with your stories. Ruth McClelland-Nugent is available for interviews; simply click on her icon now to arrange a time to talk today.
Aston University teams up with eye care provider to reduce NHS patient backlog
Aston University and Eye Docs Ltd enter Knowledge Transfer Partnership to establish new shared-care regimes for eye care patients The new model will help patients access Eye Docs surgeons It will help reduce NHS waiting lists, outpatient clinic backlogs, improve patient care and deliver profits of over £8.8 million Aston University has teamed up with private ophthalmic services clinic, Eye Docs, to undertake a 32-month Knowledge Transfer Partnership (KTP), to help clear NHS surgery waiting-lists and outpatient backlogs. In the West Midlands, average NHS waiting times have increased to over 12 months due to the impact of the Covid-19 pandemic, with waiting list contracts ranging from 100 to 1,500 patients. A cross-disciplinary team from Aston University’s School of Optometry and Aston Business School will work with West Midlands-based company Eye Docs to create a ‘shared-care’ model as part of the KTP. A KTP is a three-way collaboration between a business, an academic partner and a highly qualified researcher, known as a KTP associate. The working model will encompass clinical optometry and management science expertise to identify which patient appointments could be undertaken in community practices and which need to be seen by Eye Docs surgeons. It is hoped this way of working will also help reduce pressure on the NHS - creating a more efficient and cost-effective model that will benefit all stakeholders from patients to clinicians. The Aston University team will be led by Professor Shehzad Naroo, professor of optometry, who brings expertise in leading multidisciplinary groups and managing projects that improve eye care service delivery. Professor Naroo has a long history of working with private clinics to improve delivery of eye care, increasing efficiency and widening the role of private clinics to support the NHS. He will be supported by Professor Prasanta Dey, professor in operations and information management, whose research interests are in project management, service operations management, supply chain management and applications of multi-criteria decision making in industry. Completing the team will be Dr Yang Zhao, senior lecturer in operations and information management, whose research interests are in business model design, digital business models, platform business models, digital innovation, digital healthcare and digitalisation in aging societies. Professor Shehzad Naroo, professor of optometry at Aston University, said: “It is a privilege to be involved in this KTP, which will enable Eye Docs to increase patient numbers to fully utilise theatre capacity by receiving more surgical referrals from local optometrists. “We’re thrilled to be able to help Eye Docs to offer community-based services to patients and help to reduce the burden on the NHS.” Professor Shah, consultant ophthalmic surgeon and co-owner of Eye Docs, said: “This partnership will allow us to adopt the latest research and expertise from a world-leading academic institute to develop new patient pathways and shared-care regimes, enabling us to grow our business and profitability, develop new services and improve patient care. “Working with a multidisciplinary team of clinical and business experts from Aston University will help us to achieve the aims of this project.”
How Colorism Impacts Professional Achievement
Melissa J. Williams is associate professor of organization and management at Emory University’s Goizueta Business School. She investigates what happens when social identities collide with workplace hierarchies, and the consequences of putting people in positions of power and leadership. Here she looks at something less documented: the extent to which our appearance is stereotypically Black or white. And what that means for our prospects. Rosa Parks made history on December 1, 1955, when she refused to relinquish her bus seat to a white passenger. Her simple gesture of defiance ignited a city-wide bus boycott in Montgomery, Alabama, and has gone down in the annals as a pivotal moment for the social justice movement in the United States. However, Parks was not the only African American to make a stand against racial segregation. Nor was she the first. In March of the same year in the same city, 15-year-old Claudette Colvin also refused to give up her seat to a white woman on a Montgomery bus. So why isn’t she a household name? In part, Colvin’s age was a factor. The National Association for the Advancement of Colored People and other Black civil rights groups got behind Parks, reasoning that an older woman would be better equipped to withstand the controversy. But as Colvin herself stated, there were other factors at play. There was something about Parks’ appearance that gave her more leverage, reasons Colvin explained in Philip Hoose’s award-winning book on the civil rights movement. She had the “right hair and the right look.” Not only that, but her appearance “was the kind that people associate with the middle class. She fit that profile.” Success isn’t black or white. It’s shades of…white. Colorism has long been documented in the U.S. and elsewhere. Discrimination against human beings on the basis of their facial features, hair, and skin color transcends race—it is prevalent even within groups that share the same ethnic identity, where lighter skin tones are perceived to be more valuable than dark. Research over the years has shed light on the nefarious effects of colorism or shadeism in terms of equity and access to opportunity. But a new landmark study by Associate Professor of Organization & Management Melissa Williams, and Goizueta colleagues, PhD student Tosen Nwadei and Roberto C. Goizueta Chair of Organization & Management Anand Swaminathan, looks at just how Black or white someone appears—and how this shapes the way others see their potential; as well as the kinds of professional outcomes they can expect. What Williams and her co-authors, who also include James B. Wade from George Washington University and C. Keith Harrison and Scott Bukstein of University of Central Florida, find in their studies, is that Black professionals are less likely to be promoted to leadership roles. What’s more, for Black professionals whose physical appearance is more Black-stereotypical, their chances drop from 12 percent to a mere seven percent. For white professionals, on the other hand, having a more white-stereotypical appearance is an advantage for leadership – looking more stereotypical as a white person increased their chances of holding a leadership role from 32 percent to 43 percent. Williams and colleagues ran both an archival study and a lab experiment with volunteers to discover the extent to which degrees of ethnicity in appearance influence perceptions of a person’s potential for leadership and actually predict their likelihood of success in an industry. While the science unequivocally shows that white people enjoy advantages over Black people in opportunity and outcome across the board, Williams et al. were also interested in exploring what she calls the “continuum of race:” the more nuanced racial characteristics and differences that shape how the world sees us. There’s an assumption that everyone within the same ethnic group—Black or white—will experience the same degree of bias and prejudice, or acceptance and success. And we wanted to push back on that idea to really explore how degrees of whiteness or Blackness play out in people’s minds and shape how they read you physically. -Associate Professor of Organization & Management Melissa Williams Previous research shows the link between persisting in STEM-based majors in college and how much students are perceived to look “like their race,” she says. Those who are perceived to look less typically Black tend to make more friends outside their ethnic group—a boundary-crossing behavior that can help drive careers. To test these ideas, Williams and co-authors ran two studies. First, they accessed publicly available data including photographs, professional background, and positions from one large industry within the U.S.: American college football. College football is really rich in data. You can access job titles, photos, leadership, and non-leadership roles; and you can separate individuals out into head coaches and position coaches who have overseeing roles but who are not leaders per se. Separately, Williams et al. recruited a group of volunteers to look at the images of the football coaches: a mix of Black and white head and position coaches. These volunteers were asked to rate how typical they perceived each individual’s appearance to be of European or white Americans, or of Black Americans, ascribing each person a score out of five based on features such as their skin color, hair, eyes, nose, cheeks, and lips. These scores were then regressed—or cross-referenced—with the position held by the individuals in the photos to determine the relationship between their racial stereotypicality and their leadership role. Crunching the numbers, Williams found a direct correlation between the degree of perceived whiteness or Blackness of the coaches and how likely they actually were to be successful leaders. “We do find a kind of consensus in people’s view of what it means to be Black or white straight off,” says Williams. “So we do all seem to agree on the physical attributes of race. But it gets really interesting when you regress the scores that these photos get and compare them with the actual jobs these guys hold.” What we see is that, controlling for their age, attractiveness, and professional experience, the white guys who look less stereotypically white are 32 percent likely to occupy leadership roles. This rises to 43 percent with the men who look more like a stereotypical white guy. For Black professionals, the inverse is true, she notes. The more typically Black an individual looks, the less probability there is that he occupies a leadership job. Specifically, that figure drops from 12 to seven percent. So benchmark leadership probability is not only already lower for Black individuals, but drops even further when people are deemed to look “more typically Black,” says Williams. A follow-up experiment invited volunteer football fans to compare how they saw the potential future success of two same-race college football players—one more stereotypical in appearance than the other. The results confirm what Williams et al. suspect: 70 percent of the time, participants chose the more-typical white individual over the less-typical white individual as having greater leadership potential. In other words, the more white a white person looks, the more they are seen as leadership material. These findings should translate into an imperative, says Williams; and that is to think more broadly about race and how it impacts life outcomes. Because race is not a uniform experience, she says. “Organizations might want to look beyond just ticking the box when it comes to diversity and inclusion, and give deeper thought to who they want to recruit, support and push forward in representation. For white people, paying attention to whiteness—the types of white people who enjoy advantages in leadership—can be useful in reframing certain questions. A good place to start might be for leaders to ask: do I want to support people who look like me? Because the face you choose can ultimately help disrupt, or reinforce, the stereotype.” Interested in learning more or connecting with Melissa J. Williams, associate professor of organization and management at Emory University’s Goizueta Business School? She's available to speak about this subject - Simply click on her icon now to arrange an interview today.
#ExpertPerspective: Did the Covid-19 Pandemic Change Perspectives on Inequality?
Did the COVID-19 pandemic have a silver lining? According to Professor Andrea Dittmann and an interdisciplinary team of researchers, the answer is, “Yes.” In 2020, when it became clear that the COVID-19 pandemic would upend daily life, Andrea Dittmann decided the research she’d been doing could wait. Typically, Dittmann, Assistant Professor of Organization & Management, studies the sources of—and solutions to—inequality in the workplace. “The pandemic is a very distressing thing, but from a research standpoint it’s fascinating to study,” Dittmann said. “The pandemic laid bare all of the inequalities that I’ve been studying for years.” Dittmann, along with colleagues Ellen Reinhart and Hazel Rose Markus from the Department of Psychology, Stanford University; Rebecca Carey, Department of Psychology, Princeton University; Nicole Stephens, Management and Organizations, Northwestern’s Kellogg School of Management; and Hannah Birnbaum, Organizational Behavior Area, Olin Business School at Washington University in St. Louis, decided to study how experiencing personal harm as a result of the Covid-19 pandemic influenced people’s attitudes and behaviors towards equality. In their paper, “Personal Harm from the Covid-19 pandemic predicts advocacy for equality,” published in the January 2023 issue of Journal of Experimental Social Psychology, the researchers write that experiencing greater personal harm in the early stages of the pandemic was “associated with increased advocacy for equality one year later.” These findings are noteworthy. For decades, psychologists have studied Americans’ tendency to rationalize existing inequality as a consequence of individual or “internal” attributes (e.g. differences in work ethic) rather than as a product of larger structural, external, and uncontrollable factors such as bad luck, discrimination, or differences in educational opportunities. “Americans tend to explain people’s life outcomes as free from the constraints of history, other people, and social systems. Instead, life outcomes are seen as a product of individuals’ personal preferences, choices, or enduring characteristics,” they write. Lessons from Firsthand Experience While previous studies have shown that increasing a person’s exposure to inequality—for instance, working in an under-served school or participating in a poverty simulation—can increase people’s endorsement of external attributions for inequality, the COVID-19 pandemic presented the researchers with a real life opportunity to test their hypothesis: that an individual’s firsthand experience of personal harm due to an external force beyond his or her control “will be associated with an increase in their advocacy for equality over time,” they write. Firsthand exposure to inequality confronts people with information contrary to the dominant narrative; it demonstrates how forces beyond individuals’ control can shape people’s opportunities. To conduct their study, the authors recruited a balanced sample (in terms of gender and educational level) of approximately 1500 U.S. citizens between the ages of 18-70. Over the course of a year, they surveyed the participants three times—in May 2020, October 2020 and May 2021. Participants were asked whether they had experienced personal harm as a result of the pandemic (such as disruptions to sleep, poor mental health, financial difficulties, contracting the disease, or having a friend/family member die from the disease) and whether or not experiencing such harm was associated with greater endorsement of external attributions for inequality. Increased Advocacy: A Silver Lining To measure attitudinal and behavioral advocacy for equality, the study included questions about whether there should be universal healthcare, whether the government should provide stimulus checks to help people meet basic needs, and whether or not participants had done anything to combat inequality as a result of the personal harm they had experienced. Had they contacted a public official to express support for reducing social or economic inequality? Had they posted or shared content online that related to reducing social or economic inequality? Even when we ran the most conservative statistical tests, we were still seeing this meaningful relationship between experiencing personal harm and changing your attitude towards inequality and being more willing to stand up and do something about inequality. It speaks to the importance of having direct experience with something that has a disproportionate effect on your life. Dittmann doesn’t know if these attitudinal shifts will be permanent, but she believes the results of the study suggest that research interventions, like asking people to think about people they know who are affected by “large, external shocks” such as climate change or a natural disaster, “could be a way, experimentally, to get more people to see the link, to make these external attributions,” she explained. “While it’s of course awful that so many people experienced this harm due to the pandemic, if there is one good thing that came of it, people were able to shift their attitudes towards inequality. And very importantly, as someone who has done a lot of social psychological research, you don’t expect these effects to persist this long over time. They tend to be more transient. But this study suggests that these could be relatively long term effects.” Looking to know more? Then let us help with your media coverage or research. Andrea is an Assistant Professor of Organization & Management at Emory University's Goizueta Business School. She studies diversity and inequality, particularly employees' social class backgrounds, aiming to promote equity and inclusion at work. Andrea is available to speak with media - simply click on her icon now to arrange an interview today.
Aston University to celebrate 100 years of pharmacy education and research
Aston Pharmacy School to celebrate 100 year anniversary during 2023 The history of teaching pharmacy at Aston University dates back to the 1890s In 2016 the Pharmacy School was awarded a Regius Professorship by HM Queen Elizabeth II. Aston University is gearing up to celebrate 100 years of pharmacy education and research this year. In 1923 the Birmingham Municipal Technical School started to offer full time pharmacy courses to applicants from the general public. The roots of pharmacy education at Aston University date back to the 1890s and more significantly to 1919 when it first started teaching the subject as part of the Chemistry department at the Birmingham Municipal Technical School - as part of a funded package of training and education for returning servicemen after the First World War. In 1923 the pharmacy training provision expanded, taking on six specialist pharmacy staff within the pharmacy section of the Department of Chemistry. That year the Technical School began to offer full time pharmacy courses open to applications from the general public. In 1926 Harry Berry was appointed as head of a separate Department of Pharmacy - following an inspection by the University of London and a positive report. This distinct identity was further cemented a year later in 1927, when Neville Chamberlain, who was the then Minister for Health, opened the new teaching facilities in the School of Pharmacy in the Birmingham Central Technical College. Since then, the University has graduated thousands of pharmacy students with more than 2700 graduates in the last 20 years. Aston University’s Pharmacy School is now recognised as one of the outstanding pharmacy schools in the UK and has been at the forefront of scientific advances over the last 100 years. Its researchers developed the $2 billion blockbuster drug Temozolomide, the leading treatment for brain tumours and it created the UK's first Masters programme for hospital pharmacists. In 2016, Aston Pharmacy School was awarded a Regius Professorship by HM Queen Elizabeth II to mark her 90th birthday. It was the first time a pharmacy school had been given the award, a rare and prestigious honour bestowed by the Sovereign to recognise exceptionally high-quality research. The first holder of the title of Regius Professor of Pharmacy at Aston University was Keith Wilson, a pharmacy academic who helped to shape current and future pharmacy education both within the UK and internationally. Dr Joe Bush, head of Aston Pharmacy School, at Aston University said: "100 years of pharmacy education is a major milestone. We are immensely proud of all our achievements, from producing exceptional graduates who make a significant contribution to the professional workforce in a variety of near-patient settings, to our research discoveries and developments which have positively impacted patient healthcare and the high quality of this research having been recognised via the award of the first ever Regius Chair for Pharmacy. “It is an honour to be a part of Aston Pharmacy School, whose humble beginnings have grown to produce world class research and exceptional graduates. I look forward to celebrating with the rest of the school over the course of the year.” Celebrations of the centenary anniversary will include a celebratory lunch for staff, former staff, students and alumni to recognise the significant contributions that the school has made in research discoveries and teaching. The school will host an exhibition about the last 100 years of pharmacy at Aston University, with a range of historical artefacts on display in the entrance to the University’s main building and there will be a social media campaign to highlight key facts about the last 100 years of pharmacy at Aston University. Did you study pharmacy at Aston University? We would love to hear from you with any stories, memories from your student days. And we would love to hear about where your pharmacy career has taken you. Please get in touch with our alumni team here.
MEDIA RELEASE: Five ways to cut costs on travel; plus, the one thing you should never skip
Manitobans love to travel, but with costs rising due to inflation, it has become more important than ever to find ways to save money, while still crossing off destinations on your bucket list. “This year, more and more people across the province are eager to embark on their next adventure, whether that means disconnecting in a tropical paradise or exploring the history of an ancient city,” says Susan Postma, regional manager, CAA Manitoba. “While we are seeing a renewed interest in travel, we know the costs associated with it will be factor for many people.” With the help of our travel professionals, CAA Manitoba (CAA MB) has compiled a few tips to help save you money. Plan ahead. Start planning your trip well in advance of your departure date. Determine what your budget will allow and book flights, hotels, and rental cars early to get the best deals and rates possible. With the higher demand for travel, last-minute planning will result in higher airfares, hotel rates and even disappointment from no availability. Redeem your loyalty points or member benefits. Use frequent flyer miles or credit card points to pay for flights or hotels. Take advantage of CAA member benefits and discounts at hotels and attractions, or tap into hotel loyalty programs. Now is your time to finally redeem all those accumulated rewards points from a member program or credit card. Also, don’t forget to check the expiration date on unused vouchers or credits. Look for hotels that include breakfast or allow self-catering. Food costs continue to rise and will quickly eat into your budget when you’re paying for three meals (+ snacks) each day. A free breakfast, offered by many hotels, or a hotel room with a kitchenette or fridge will help reduce food costs and give you more money to put towards excursions and other experiences while you’re away. Travel during off-peak times. There are both days of the week and times of the year that are cheaper to travel. Consider travelling during these off-peak times or leaving for your trip during the week versus on a weekend. Partner with a travel agent to get the best deal. A travel agent will know when there are active sales. Travel promotions happen several times throughout the year, and a trusted travel agent will know the best time to book your next getaway. While everyone likes a great deal, the one thing you should never skip is travel insurance says Postma. “You may be in good health before your departure, but unexpected medical emergencies can still happen while you are away from home. If you get sick or injured, travel insurance is important to ensure your medical treatment is covered, along with any related out-of-pocket expenses.” If you're uncertain what coverage you need, CAA encourages you to talk to your travel insurance expert who can help you find the most suitable coverage for your trip and your needs.
MEDIA RELEASE: Five ways to cut costs on travel; plus, the one thing you should never skip
Ontarians love to travel, but with costs rising due to inflation, it has become more important than ever to find ways to save money, while still crossing off destinations on your bucket list. “This year, more and more people across the province are eager to embark on their next adventure, whether that means disconnecting in a tropical paradise or exploring the history of an ancient city,” says Susan Postma, regional manager, CAA Club Group. “While we are seeing a renewed interest in travel, we know the costs associated with it will be factor for many people.” With the help of our travel professionals, CAA South Central Ontario (CAA SCO) has compiled a few tips to help save you money. Plan ahead. Start planning your trip well in advance of your departure date. Determine what your budget will allow and book flights, hotels, and rental cars early to get the best deals and rates possible. With the higher demand for travel, last-minute planning will result in higher airfares, hotel rates and even disappointment from no availability. Redeem your loyalty points or member benefits. Use frequent flyer miles or credit card points to pay for flights or hotels. Take advantage of CAA member benefits and discounts at hotels and attractions, or tap into hotel loyalty programs. Now is your time to finally redeem all those accumulated rewards points from a member program or credit card. Also, don’t forget to check the expiration date on unused vouchers or credits. Look for hotels that include breakfast or allow self-catering. Food costs continue to rise and will quickly eat into your budget when you’re paying for three meals (+ snacks) each day. A free breakfast, offered by many hotels, or a hotel room with a kitchenette or fridge will help reduce food costs and give you more money to put towards excursions and other experiences while you’re away. Travel during off-peak times. There are both days of the week and times of the year that are cheaper to travel. Consider travelling during these off-peak times or leaving for your trip during the week versus on a weekend. Partner with a travel agent to get the best deal. A travel agent will know when there are active sales. Travel promotions happen several times throughout the year, and a trusted travel agent will know the best time to book your next getaway. While everyone likes a great deal, the one thing you should never skip is travel insurance says Postma. “You may be in good health before your departure, but unexpected medical emergencies can still happen while you are away from home. If you get sick or injured, travel insurance is important to ensure your medical treatment is covered, along with any related out-of-pocket expenses.” If you're uncertain what coverage you need, CAA encourages you to talk to your travel insurance expert who can help you find the most suitable coverage for your trip and your needs.
• Researchers in the School of Biosciences partner with preclinical-stage biotechnology start-up company to develop drugs for fibrotic diseases • Professor Martin Griffin and team develop TG2 inhibitors to help treat a serious chronic lung disease called idiopathic pulmonary fibrosis. • Isterian Biotech is part of Cambrian BioPharma who have been working with Aston University since 2019. Aston University scientists are working with start-up company, Isterian Biotech, part of Cambrian BioPharma, to develop novel drugs to treat fibrotic diseases such as lung disease. The focus of preclinical-stage biotechnology company Isterian Biotech is on developing novel drugs to stop or reverse the pathological accumulation of crosslinked proteins commonly observed in all major organs with age. As we age a chronic increase of crosslinked proteins occurs in the extracellular matrix (ECM), that surround, support, and give structure to the cells and tissues in the body. These crosslinked proteins are difficult for the body to degrade and over time can make organs stiff and dysfunctional, ultimately resulting in fibrosis. Reversing the accumulation of these pathological crosslinks will greatly contribute to reducing fibrosis. The start-up is working to develop small molecule inhibitors of transglutaminase 2 also known as TG2, which is one of the major crosslinking enzymes in the human body, that becomes more active during ageing - thus resulting in fibrotic diseases such as a type of lung disease known as idiopathic pulmonary fibrosis (IPF). Isterian President and Chairman of the Board, Georg C Terstappen, PhD said: "Isterian's strategy of combining rational drug design with efficient multiparametric profiling of synthesized small molecules has been both impressive and highly productive. Notably, for one of our highly potent and selective TG2 inhibitors, we have recently demonstrated efficacy in a mouse model of lung fibrosis for the first time. "Using this state-of-the-art approach to drug discovery combined with an impressive team gives us great confidence in the future of this novel company." IPF is a progressive, irreversible disease that is characterized by pathological crosslinking of extracellular matrix (ECM) proteins (a large network of proteins and other molecules that surround, support, and give structure to the cells and tissues in the body) leading to excessive deposition of collagen. This means that in IPF scar tissue or fibrosis builds up around the air sacs (alveoli) in the lungs and reduces the ability to transfer oxygen that is breathed into the blood, resulting in severe restriction of lung capacity and function. IPF is the most common form of pulmonary fibrosis. The disease affects between 200,000 and 300,000 people globally. Statistics from the charity Action for Pulmonary Fibrosis suggest there are about 30,000 people living with IPF in the UK with an estimated 6,000 new cases of the condition each year. The disease usually develops in people aged 70 and older and is more common in men. But it can occur in younger individuals, particularly if there is a family history of idiopathic pulmonary fibrosis. The company was founded by capitalizing on over 35 years of scientific research from the laboratory of Professor Martin Griffin and his team Dr Dan Rathbone and Dr Vivian Wang at Aston University. Their work with small molecule inhibitors selective for TG2 has demonstrated reduction of fibrosis in multiple organs in a number of animal models. In 2019, Aston University partnered with Cambrian to form Isterian Biotech with a mission to develop safe and effective TG2 inhibitors to treat Idiopathic pulmonary fibrosis (IPF), a devastating fibrotic disease of the lung. Professor Martin Griffin, Biosciences Research Group, Aston University said: “We are delighted to continue our work with Isterian researching how we can further develop TG2 inhibitors to help tackle this awful disease.” CEO of Cambrian BioPharma, James Peyer, commented: "As Cambrian continues on its mission to build medicines that will redefine healthcare in the 21st century, we are very thankful to find brilliant scientists such as Martin and his team that are willing to break the mold. Isterian and its work to reduce fibrosis are a perfect fit alongside the other pipeline companies our team has announced in 2022." The company's current pipeline includes an advanced preclinical-stage TG2 inhibitor for inhaled administration and several structurally unrelated back-up compounds for the treatment of IPF. For more information about the School of Biosciences at Aston University, please visit our website.